India to Canada: Ciprofloxacin Export Trade Route

The India to Canada Ciprofloxacin corridor is one of India's established pharmaceutical export routes, with 121 shipments documented worth a combined $4.1M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's ciprofloxacin manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $34.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with ciprofloxacin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 34.7%, placing it at rank #19 among India's top ciprofloxacin export destinations globally.

On the import side, key buyers of Indian ciprofloxacin in Canada include TARO PHARMACEUTICALS INC.,, ROPACK PHARMACEUTIQUE INC, AURO PHARMA INC and 33 others. TARO PHARMACEUTICALS INC., is the single largest importer with 9 shipments valued at $1.8M USD.

India's ciprofloxacin exports to Canada are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, WATSON PHARMA PRIVATE LIMITED, AUROBINDO PHARMA LTD — together account for 69% of total trade value on this route. The average shipment value of $34.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ciprofloxacin (0.3%) and dexamethasone (0.1%) sterile otic suspension usp, 7.5ml[45699 pack x 1 bottle] (batch no. baf0 and ciprofloxacin tablets usp 500 mg batch n, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TARO PHARMACEUTICALS INC., is the largest importer with 9 shipments worth $1.8M USD — representing 43% of all ciprofloxacin imports from India on this route. A total of 36 buyers are active on this corridor.